San Francisco, CA-based venture capital firm Spruce Capital Partners, LLC, co-manager of the Malaysian Life Sciences Capital Fund I and MLS Capital Fund II, named Dr. Jonathan Burbaum as an entrepreneur-in-residence.
Dr. Burbaum will evaluate opportunities to initiate new businesses for MLS Capital Fund II. Among the opportunities he is expected to explore include ways to improve crop productivity, increase the nutritional content of plants, and enhance their value as food and feedstocks.
Prior to joining Spruce, Dr. Burbaum served as a Program Director at the Advanced Research Projects Agency-Energy (ARPA-E). He founded two startups, both based in San Diego, and has worked for corporate, venture, and government clients.
Before entering consulting, he played seminal roles with two venture-backed startup companies. He served as Associate Director of Princeton, New Jersey-based Pharmacopeia from inception through its initial public offering and commercial launch, and as Vice President of Research for San Diego-based ActivX Biosciences.
He began his industrial career at the Merck Research Laboratories in 1991.
Led by Dr. Ganesh Kishore, Dr. Roger Wyse, and Greg Young, Spruce Capital Partners provides management and leadership support to early through mid stage innovative businesses operating in such areas as agriculture, agtech, biotech, biogreentech, industrial biotech, food and nutrition.